Major vascular events occurred in 1477 ( 245 % ) participants allocated 80 mg simvastatin versus 1553 ( 257 % ) of those allocated 20 mg , corresponding to a 6 % proportional reduction ( risk ratio 094 , 95 % CI 088-101 ; p = 010 ) .
